TABLE 4

Net Yield for Vaccine Purchase Across Practices

VaccineBrandNo. of PracticesNet Yield Per Dose, $
MeanMaximumMinimum (Percent < 0)
Recommended childhood vaccines
    DTaPDaptacel5210.0827.800.36 (0)
Tripedia96.6712.780.55 (0)
Infanrix199.4112.781.99 (0)
    IPVIPOL727.7518.48−3.59 (4)
    MMRMMRII674.3118.92−25.77 (16)
    HibActHIB419.0231.45−1.86 (2)
PedvaxHIB302.9013.20−1.19 (10)
    Hep BRecombivax4213.6525.77−1.99 (2)
Engerix1714.4623.274.53 (0)
    VaricellaVarivax736.6135.13−29.31 (21)
    Hep AHavrix315.6122.16−3.21 (26)
VAQTA487.4922.15−5.49 (13)
    PCV7Prevnar736.1538.96−11.30 (11)
    RotavirusRotaTeq606.3526.66−8.09 (10)
Related combination vaccines
    DTaP-Hep B-IPVPediarix3524.3447.102.34 (0)
    Hep B-HibComvax2523.6235.5815.35 (0)
    MMR-VProQuad4714.7364.76−25.40 (15)
Recommended adolescent vaccines
    HPVGardasil7015.9557.92−0.94 (3)
    MCV4Menactra708.9738.58−5.66 (13)
    TdaPAdacel616.8117.19−1.12 (2)
Boostrix234.0011.31−2.08 (9)
  • DTaP indicates diphtheria-tetanus-acellular pertussis; IPV, inactivated polio vaccine; MMR, measles-mumps-rubella; Hib, Haemophilus influenzae type b; Hep, hepatitis; PCV7, heptavalent pneumococcal conjugate vaccine; V, varicella; HPV, human papillomavirus; MCV4, meningococcal conjugate vaccine; TdaP, tetanus-diphtheria-acellular pertussis. Data show the vaccine purchase reimbursement for most common payer summarized across practices.